|
2025-03-26 |
2025-03-24 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
1 698
-0.1%
9,00
15 282 USD
|
1 698
-0.1%
|
9,00
|
15 282 USD
|
|
|
2025-03-17 |
2025-03-13 |
V
Vente
|
GRIFFIN MICHELLE RENEE
Administrateur non-exécutif
|
36 291
-70.2%
7,19
260 932 USD
|
36 291
-70.2%
|
7,19
|
260 932 USD
|
|
|
2025-03-12 |
2025-03-12 |
V
Vente
|
HERSHBERG ROBERT
Administrateur non-exécutif
|
53 000
-43.2%
7,59
402 270 USD
|
53 000
-43.2%
|
7,59
|
402 270 USD
|
|
|
2025-03-12 |
2025-03-10 |
V
Vente
|
NEUPERT PETER M
Administrateur non-exécutif
|
10 000
-4.3%
7,05
70 500 USD
|
10 000
-4.3%
|
7,05
|
70 500 USD
|
|
|
2025-03-06 |
2025-03-06 |
VP
Vente planifiée
|
GRIFFIN MICHELLE RENEE
Administrateur non-exécutif
|
15 664
-23.3%
7,94
124 372 USD
|
15 664
-23.3%
|
7,94
|
124 372 USD
|
|
|
2025-03-06 |
2025-03-06 |
V
Vente
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
102 218
-3.3%
7,64
780 946 USD
|
102 218
-3.3%
|
7,64
|
780 946 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
LO FRANCIS
Chief People Officer
Dirigeant
|
13 790
-4.0%
6,99
96 392 USD
|
13 790
-4.0%
|
6,99
|
96 392 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
LO FRANCIS
Chief People Officer
Dirigeant
|
7 085
-2.0%
6,98
49 453 USD
|
7 085
-2.0%
|
6,98
|
49 453 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
BOBULSKY SUSAN
Chief Commercial Officer, MRD
Dirigeant
|
26 023
-7.0%
6,98
181 641 USD
|
26 023
-7.0%
|
6,98
|
181 641 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
PISKEL KYLE
Chief Financial Officer
Dirigeant
|
6 964
-2.5%
6,99
48 678 USD
|
6 964
-2.5%
|
6,99
|
48 678 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
PISKEL KYLE
Chief Financial Officer
Dirigeant
|
253
-0.1%
6,98
1 766 USD
|
253
-0.1%
|
6,98
|
1 766 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
PISKEL KYLE
Chief Financial Officer
Dirigeant
|
3 103
-1.1%
6,97
21 628 USD
|
3 103
-1.1%
|
6,97
|
21 628 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
BENZENO SHARON
Chief Commercial Ofc Imm Med
Dirigeant
|
3 065
-0.8%
6,99
21 424 USD
|
3 065
-0.8%
|
6,99
|
21 424 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
BENZENO SHARON
Chief Commercial Ofc Imm Med
Dirigeant
|
41 600
-9.5%
6,98
290 368 USD
|
41 600
-9.5%
|
6,98
|
290 368 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
RUBINSTEIN JULIE
President and COO
Dirigeant
|
19 461
-3.2%
6,99
136 032 USD
|
19 461
-3.2%
|
6,99
|
136 032 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
RUBINSTEIN JULIE
President and COO
Dirigeant
|
40 044
-6.2%
6,98
279 507 USD
|
40 044
-6.2%
|
6,98
|
279 507 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
56 053
-4.2%
6,99
391 810 USD
|
56 053
-4.2%
|
6,99
|
391 810 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
40 603
-3.0%
6,98
283 409 USD
|
40 603
-3.0%
|
6,98
|
283 409 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
36 145
-1.3%
6,99
252 654 USD
|
36 145
-1.3%
|
6,99
|
252 654 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
81 206
-2.8%
6,98
566 818 USD
|
81 206
-2.8%
|
6,98
|
566 818 USD
|
|
|
2025-02-21 |
2025-02-20 |
VP
Vente planifiée
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
99 107
-3.7%
8,44
836 463 USD
|
99 107
-3.7%
|
8,44
|
836 463 USD
|
|
|
2025-02-21 |
2025-02-19 |
VP
Vente planifiée
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
186 080
-6.7%
8,46
1 574 237 USD
|
186 080
-6.7%
|
8,46
|
1 574 237 USD
|
|
|
2025-02-18 |
2025-02-18 |
VP
Vente planifiée
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
211 160
-7.6%
8,50
1 794 860 USD
|
211 160
-7.6%
|
8,50
|
1 794 860 USD
|
|
|
2025-02-18 |
2025-02-14 |
VP
Vente planifiée
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
158 921
-5.8%
8,46
1 344 472 USD
|
158 921
-5.8%
|
8,46
|
1 344 472 USD
|
|
|
2025-02-18 |
2025-02-13 |
VP
Vente planifiée
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
100 287
-3.7%
8,44
846 422 USD
|
100 287
-3.7%
|
8,44
|
846 422 USD
|
|
|
2024-11-19 |
2024-11-18 |
V
Vente
|
PISKEL KYLE
Chief Financial Officer
Dirigeant
|
248
-0.2%
4,98
1 235 USD
|
248
-0.2%
|
4,98
|
1 235 USD
|
|
|
2024-08-23 |
2024-08-22 |
VP
Vente planifiée
|
Taylor Stacy L
SVP and General Counsel
Dirigeant
|
26 922
-16.2%
4,50
121 079 USD
|
26 922
-16.2%
|
4,50
|
121 079 USD
|
|
|
2024-03-06 |
2024-03-05 |
V
Vente
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
42 794
-1.6%
3,43
146 783 USD
|
42 794
-1.6%
|
3,43
|
146 783 USD
|
|
|
2024-03-06 |
2024-03-05 |
V
Vente
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
5 879
-0.2%
3,44
20 224 USD
|
5 879
-0.2%
|
3,44
|
20 224 USD
|
|
|
2024-03-06 |
2024-03-05 |
V
Vente
|
LO FRANCIS
Chief People Officer
Dirigeant
|
1 813
-0.7%
3,44
6 237 USD
|
1 813
-0.7%
|
3,44
|
6 237 USD
|
|
|
2024-03-06 |
2024-03-05 |
V
Vente
|
LO FRANCIS
Chief People Officer
Dirigeant
|
12 887
-4.8%
3,43
44 202 USD
|
12 887
-4.8%
|
3,43
|
44 202 USD
|
|
|
2024-03-06 |
2024-03-05 |
V
Vente
|
RUBINSTEIN JULIE
President
Dirigeant
|
13 490
-2.8%
3,56
48 024 USD
|
13 490
-2.8%
|
3,56
|
48 024 USD
|
|
|
2024-03-06 |
2024-03-05 |
V
Vente
|
RUBINSTEIN JULIE
President
Dirigeant
|
25 580
-5.0%
3,43
87 739 USD
|
25 580
-5.0%
|
3,43
|
87 739 USD
|
|
|
2024-03-06 |
2024-03-05 |
V
Vente
|
PETERSON TYCHO
Chief Financial Officer
Dirigeant
|
15 456
-2.8%
3,44
53 169 USD
|
15 456
-2.8%
|
3,44
|
53 169 USD
|
|
|
2024-03-06 |
2024-03-05 |
V
Vente
|
PISKEL KYLE
Principal Accounting Officer
Dirigeant
|
7 727
-5.9%
3,43
26 504 USD
|
7 727
-5.9%
|
3,43
|
26 504 USD
|
|
|
2024-03-06 |
2024-03-05 |
V
Vente
|
BOBULSKY SUSAN
Chief Commercial Officer, MRD
Dirigeant
|
6 975
-2.7%
3,44
23 994 USD
|
6 975
-2.7%
|
3,44
|
23 994 USD
|
|
|
2024-03-06 |
2024-03-05 |
V
Vente
|
BOBULSKY SUSAN
Chief Commercial Officer, MRD
Dirigeant
|
6 016
-2.3%
3,43
20 635 USD
|
6 016
-2.3%
|
3,43
|
20 635 USD
|
|
|
2024-03-06 |
2024-03-05 |
V
Vente
|
BENZENO SHARON
Chief Commercial Ofc Imm Med
Dirigeant
|
18 644
-5.4%
3,44
64 135 USD
|
18 644
-5.4%
|
3,44
|
64 135 USD
|
|
|
2024-03-06 |
2024-03-05 |
V
Vente
|
BENZENO SHARON
Chief Commercial Ofc Imm Med
Dirigeant
|
10 746
-3.0%
3,43
36 859 USD
|
10 746
-3.0%
|
3,43
|
36 859 USD
|
|
|
2024-03-06 |
2024-03-05 |
V
Vente
|
Taylor Stacy L
SVP and General Counsel
Dirigeant
|
6 609
-3.8%
3,44
22 735 USD
|
6 609
-3.8%
|
3,44
|
22 735 USD
|
|
|
2024-03-06 |
2024-03-05 |
V
Vente
|
Taylor Stacy L
SVP and General Counsel
Dirigeant
|
6 772
-3.8%
3,43
23 228 USD
|
6 772
-3.8%
|
3,43
|
23 228 USD
|
|
|
2023-11-20 |
2023-11-16 |
V
Vente
|
PISKEL KYLE
Principal Accounting Officer
Dirigeant
|
259
-0.3%
4,13
1 070 USD
|
259
-0.3%
|
4,13
|
1 070 USD
|
|
|
2023-08-08 |
2023-08-08 |
VP
Vente planifiée
|
SOOD NITIN
Chief Commercial Officer, MRD
Dirigeant
|
10 550
-4.7%
6,54
68 997 USD
|
10 550
-4.7%
|
6,54
|
68 997 USD
|
|
|
2023-08-08 |
2023-08-07 |
V
Vente
|
SOOD NITIN
Chief Commercial Officer, MRD
Dirigeant
|
5 652
-2.4%
6,78
38 321 USD
|
5 652
-2.4%
|
6,78
|
38 321 USD
|
|
|
2023-06-21 |
2023-06-20 |
VP
Vente planifiée
|
PETERSON TYCHO
Chief Financial Officer
Dirigeant
|
64 961
-14.0%
8,14
528 783 USD
|
64 961
-14.0%
|
8,14
|
528 783 USD
|
|
|
2023-06-21 |
2023-06-20 |
VP
Vente planifiée
|
PETERSON TYCHO
Chief Financial Officer
Dirigeant
|
70 000
-13.1%
8,14
569 800 USD
|
70 000
-13.1%
|
8,14
|
569 800 USD
|
|
|
2023-06-20 |
2023-06-15 |
VP
Vente planifiée
|
PETERSON TYCHO
Chief Financial Officer
Dirigeant
|
14 328
-3.5%
8,53
122 218 USD
|
14 328
-3.5%
|
8,53
|
122 218 USD
|
|
|
2023-06-20 |
2023-06-15 |
VP
Vente planifiée
|
PETERSON TYCHO
Chief Financial Officer
Dirigeant
|
55 672
-12.2%
8,53
474 882 USD
|
55 672
-12.2%
|
8,53
|
474 882 USD
|
|
|
2023-06-06 |
2023-06-02 |
V
Vente
|
PETERSON TYCHO
Chief Financial Officer
Dirigeant
|
38 000
-7.7%
7,16
272 080 USD
|
38 000
-7.7%
|
7,16
|
272 080 USD
|
|
|
2023-04-12 |
2023-04-11 |
VP
Vente planifiée
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
2 308
-1.3%
8,63
19 918 USD
|
2 308
-1.3%
|
8,63
|
19 918 USD
|
|
|
2023-04-12 |
2023-04-10 |
V
Vente
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
817
-0.5%
8,50
6 945 USD
|
817
-0.5%
|
8,50
|
6 945 USD
|
|
|
2023-03-29 |
2023-03-27 |
VP
Vente planifiée
|
GRIFFIN MICHELLE RENEE
Administrateur non-exécutif
|
2 341
-10.2%
8,49
19 878 USD
|
2 341
-10.2%
|
8,49
|
19 878 USD
|
|
|
2023-03-08 |
2023-03-07 |
VP
Vente planifiée
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
17 155
-8.8%
8,60
147 533 USD
|
17 155
-8.8%
|
8,60
|
147 533 USD
|
|
|
2023-03-08 |
2023-03-07 |
VP
Vente planifiée
|
SOOD NITIN
Chief Commercial Officer, MRD
Dirigeant
|
9 813
-4.1%
8,60
84 392 USD
|
9 813
-4.1%
|
8,60
|
84 392 USD
|
|
|
2023-03-08 |
2023-03-07 |
VP
Vente planifiée
|
Taylor Stacy L
SVP and General Counsel
Dirigeant
|
13 387
-8.7%
8,60
115 128 USD
|
13 387
-8.7%
|
8,60
|
115 128 USD
|
|
|
2023-03-08 |
2023-03-06 |
V
Vente
|
PISKEL KYLE
Principal Accounting Officer
Dirigeant
|
229
-0.3%
8,58
1 965 USD
|
229
-0.3%
|
8,58
|
1 965 USD
|
|
|
2023-03-08 |
2023-03-06 |
V
Vente
|
PISKEL KYLE
Principal Accounting Officer
Dirigeant
|
3 300
-3.6%
8,57
28 281 USD
|
3 300
-3.6%
|
8,57
|
28 281 USD
|
|
|
2023-03-08 |
2023-03-06 |
V
Vente
|
LO FRANCIS
Chief People Officer
Dirigeant
|
6 816
-3.9%
8,57
58 413 USD
|
6 816
-3.9%
|
8,57
|
58 413 USD
|
|
|
2023-03-08 |
2023-03-06 |
V
Vente
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
6 529
-3.2%
8,57
55 954 USD
|
6 529
-3.2%
|
8,57
|
55 954 USD
|
|
|
2023-03-08 |
2023-03-06 |
V
Vente
|
SOOD NITIN
Chief Commercial Officer, MRD
Dirigeant
|
6 661
-2.7%
8,57
57 085 USD
|
6 661
-2.7%
|
8,57
|
57 085 USD
|
|
|
2023-03-08 |
2023-03-06 |
V
Vente
|
Taylor Stacy L
SVP and General Counsel
Dirigeant
|
5 491
-3.5%
8,57
47 058 USD
|
5 491
-3.5%
|
8,57
|
47 058 USD
|
|
|
2023-03-08 |
2023-03-06 |
V
Vente
|
BENZENO SHARON
Chief Commercial Ofc Imm Med
Dirigeant
|
11 749
-5.0%
8,57
100 689 USD
|
11 749
-5.0%
|
8,57
|
100 689 USD
|
|
|
2023-03-08 |
2023-03-06 |
V
Vente
|
RUBINSTEIN JULIE
President
Dirigeant
|
22 668
-6.3%
8,57
194 265 USD
|
22 668
-6.3%
|
8,57
|
194 265 USD
|
|
|
2023-01-11 |
2023-01-10 |
VP
Vente planifiée
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
2 130
-1.8%
8,58
18 275 USD
|
2 130
-1.8%
|
8,58
|
18 275 USD
|
|
|
2023-01-11 |
2023-01-09 |
V
Vente
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
995
-0.9%
8,50
8 458 USD
|
995
-0.9%
|
8,50
|
8 458 USD
|
|
|
2022-11-17 |
2022-11-16 |
V
Vente
|
PISKEL KYLE
Principal Accounting Officer
Dirigeant
|
959
-2.0%
8,87
8 506 USD
|
959
-2.0%
|
8,87
|
8 506 USD
|
|
|
2022-11-01 |
2022-11-01 |
VP
Vente planifiée
|
SOOD NITIN
Chief Commercial Officer, MRD
Dirigeant
|
31 066
-21.3%
8,00
248 528 USD
|
31 066
-21.3%
|
8,00
|
248 528 USD
|
|
|
2022-10-11 |
2022-10-10 |
VP
Vente planifiée
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
2 284
-1.9%
7,13
16 285 USD
|
2 284
-1.9%
|
7,13
|
16 285 USD
|
|
|
2022-10-11 |
2022-10-07 |
V
Vente
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
841
-0.7%
7,61
6 400 USD
|
841
-0.7%
|
7,61
|
6 400 USD
|
|
|
2022-08-05 |
2022-08-05 |
V
Vente
|
SOOD NITIN
Chief Commercial Officer, MRD
Dirigeant
|
17 540
-10.8%
10,98
192 589 USD
|
17 540
-10.8%
|
10,98
|
192 589 USD
|
|
|
2022-07-08 |
2022-07-08 |
VP
Vente planifiée
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
2 300
-1.9%
10,47
24 081 USD
|
2 300
-1.9%
|
10,47
|
24 081 USD
|
|
|
2022-07-08 |
2022-07-07 |
V
Vente
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
825
-0.7%
9,53
7 862 USD
|
825
-0.7%
|
9,53
|
7 862 USD
|
|
|
2022-04-08 |
2022-04-07 |
V
Vente
|
ADAMS R MARK
Chief Operating Officer
Dirigeant
|
831
-0.7%
13,17
10 944 USD
|
831
-0.7%
|
13,17
|
10 944 USD
|
|
|
2022-03-09 |
2022-03-09 |
VP
Vente planifiée
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
14 815
-0.8%
12,46
184 595 USD
|
14 815
-0.8%
|
12,46
|
184 595 USD
|
|
|
2022-03-10 |
2022-03-08 |
VP
Vente planifiée
|
BALDO LANCE
Chief Medical Officer
Dirigeant
|
3 350
-16.3%
11,43
38 291 USD
|
3 350
-16.3%
|
11,43
|
38 291 USD
|
|
